首页> Immunotherapy> Gamma heavy chain disease treated with daratumumab-based regimen: a first case report and review of literature.

Gamma heavy chain disease treated with daratumumab-based regimen: a first case report and review of literature.

导出 LinkOut

翻译打印收藏纠错

第一作者： Carla,Cicerchia

第一单位： Department of Immuno-hematology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

作者： Carla,Cicerchia ^[1] ; Tristan,Vaugeois ^[2] ; Nathalie,Forgeard ^[2] ; Jean-François,Alexandra ^[3] ; Floriane,Theves ^[1] ; Stéphanie,Harel ^[1] ; Bruno,Royer ^[1] ; Sophie,Rousselet ^[4] ; Antoine,Diep ^[5] ; Patricia,Palmic ^[6] ; Bertrand,Arnulf ^[2] ; Alexis,Talbot ^[2]

作者单位： Department of Immuno-hematology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. ^[1] Department of Immuno-hematology, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.;University of Paris Cité, Paris, France. ^[2] Department of Internal Medicine, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. ^[3] Department of Nuclear Medicine, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. ^[4] Department of Immunology and Histocompatibility, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. ^[5] Department of Pathology, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. ^[6]

关键词 CD38 Gamma heavy chain disease case report central nervous system involvement daratumumab lymphoproliferative disorders rare B-cell neoplasms

DOI 10.1080/1750743X.2025.2549673

PMID 40838430

发布时间 2025-09-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交